Le Lézard
Classified in: Health, Business
Subjects: NPT, JVN, CSR

Collaboration Between LJ Partnership and Elena Baturina Boosts Funding for Cancer Charity in London


LONDON, August 14, 2018 /PRNewswire/ --

A collaboration between LJ Partnership, the London-based private wealth partnership and real estate investor, and the structures of international businesswoman and philanthropist Elena Baturina has resulted in significant funding to London based charity Maggie's, allowing it to open a new Maggie's Barts centre at St Bartholomew's Hospital this year and enabling its Maggie's Centre at the Royal Marsden Hospital to undergo construction and development work. Maggie's Centres provide practical, emotional and social support to cancer patients, their family and friends.

Elena Baturina serves as Vice President of Maggie's and is passionate about its cause. Both she and LJ Partnership hold a similar vision for the way large businesses should support important charitable and socially beneficial projects.

Elena Baturina, said: "It is my firm belief that money is not the goal, but means to make a positive change. I am convinced that business must provide support to vital causes. I hope that our support will allow Maggie's Centres to help more and more people affected by cancer, whilst also attracting more attention to the problem."

Andrew Williams, Chairman of LJ Partnership, said: "We feel privileged to work with people who share our views, not only in terms of business strategies, but also social responsibility and important charitable causes. The work that Maggie's does is vital and we are dedicated to continuing our support."

Laura Lee, CEO of Maggie's said: "We are very grateful to LJ Partnership and Elena Baturina for their help in supporting our charity which is so important for cancer patients and their families. The increase in funding has allowed us to open a new centre at St Bartholomew's and a 2nd Centre start construction at Royal Marsden Hospital.  The help we get from our loyal patrons is invaluable to our continuing work allowing Maggie's to give vital support to people with cancer and their families and friends."  

LJ Partnership advises $15 billion of assets on behalf of around 250 clients including individuals, families, foundations and institutions, delivering investment and administration services, acting as both a trusted advisor and principal co-investor.

Elena Baturina is a businesswoman and philanthropist, whose international career has spanned a spectrum of industries, from manufacturing to hospitality. The latest Forbes ranking lists her as the only Russian female billionaire; self-made in the construction industry; her fortune now constitutes USD1.2bn.


These press releases may also interest you

at 06:30
Boston Scientific Corporation generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported basis, 15.0 percent on an operational1 basis and 13.1 percent on an organic2 basis, all compared to the prior...

at 06:28
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Pharma Parenteral Packaging Market ? By Drug Type (Small Molecules, Biologics, Vaccines, Biosimilars, & Others), By Product Type (Bottles, Ampoules,...

at 06:15
Overall 8.46 Average Revised Venous Clinical Severity Score (rVCSS) Improvement Per Patient for Patients Showing Clinical Meaningful Benefit (rVCSS Improvement ≥ 3 Points) including:9.29 Points for Patients at the Two-Year Milestone8.08 Points...

at 06:10
Thermo Fisher Scientific Inc. , the world leader in serving science, will hold its 2024 Investor Day on Thursday, September 19, starting at 9:00 a.m. (ET) in New York City. The format will feature presentations by members of Thermo Fisher...

at 06:05
Thermo Fisher Scientific Inc. , the world leader in serving science, today reported its financial results for the first quarter ended March 30, 2024. First Quarter 2024 Highlights First quarter revenue was $10.34 billion. First quarter GAAP...

at 06:05
Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, announced today that it will release financial results for the first quarter ended March 31, 2024 after the close of trading on Wednesday, May 8. Biodesix's...



News published on and distributed by: